ProCE Banner Activity

Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer

Slideset

Downloadable slideset with the latest expert guidance on germline BRCA testing and targeting in patients with HER2-negative early-stage breast cancer.

Released: May 07, 2024

Expiration: May 06, 2025

Share

Faculty

Tanya Gupta

Tanya Gupta, MD

Clinical Assistant Professor
Breast Oncology
Stanford Healthcare
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC in partnership with Breastcancer.org

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner